Principal Street Partners’s Boston Scientific BSX Stock Holding History

Principal Street Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,158	Closed	-$206K	–	252
2025 Q4	$206K	Hold	2,158	–	–	0.03%	226
2025 Q3	$211K	Sell	2,158 -2,170	-50%	-$225K	0.03%	246
2025 Q2	$465K	Buy	4,328 +2,272	+111%	+$230K	0.05%	209
2025 Q1	$207K	Buy	+2,056	New	+$207K	0.04%	219

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Principal Street Partners's BSX Position: Q1 2026 in Review

Principal Street Partners sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,158 shares — an estimated $206K sold.

Principal Street Partners first reported a position in BSX in Q1 2025 and held it in 4 quarters. The position peaked at $465K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Principal Street Partners reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Principal Street Partners sold 2,158 Boston Scientific shares in Q1 2026, an estimated $206K.
Principal Street Partners first reported a position in Boston Scientific in Q1 2025 and held it in 4 quarters.
Principal Street Partners's Boston Scientific position peaked at $465K in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Principal Street Partners's 13F filing for Q1 2026, filed 15 May 2026.